Riik: Iisrael
keel: inglise
Allikas: Ministry of Health
PIOGLITAZONE AS HYDROCHLORIDE
ABIC MARKETING LTD, ISRAEL
A10BG03
TABLETS
PIOGLITAZONE AS HYDROCHLORIDE 15 MG
PER OS
Required
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
PIOGLITAZONE
Pioglitazone Teva is indicated as second or third line treatment of type 2 diabetes mellitus as described below: as monotherapy- in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with- metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.Pioglitazone Teva is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance .
2020-09-30
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 The medicine is dispensed with a doctor’s prescription only Pioglitazone Teva 15 mg Pioglitazone Teva 30 mg Pioglitazone Teva 45 mg Tablets Composition: Each tablet of Pioglitazone Teva 15 mg contains: Pioglitazone (as hydrochloride) 15 mg Each tablet of Pioglitazone Teva 30 mg contains: Pioglitazone (as hydrochloride) 30 mg Each tablet of Pioglitazone Teva 45 mg contains: Pioglitazone (as hydrochloride) 45 mg For information regarding inactive ingredients and allergens in the preparation see section 2 – “Important information about some of the ingredients of the medicine” and section 6 – “Additional information”. Read the entire leaflet carefully before using the medicine. This leaflet contains concise information about the medicine. If you have additional questions, refer to the doctor or the pharmacist. This medicine has been prescribed for treatment of your illness. Do not pass it on to others. It may harm them even if it seems to you that their medical condition is similar. The medicine is not intended for children and adolescents under the age of 18 years. 1. WHAT IS THE MEDICINE INTENDED FOR? The medicine is intended for the treatment of type 2 diabetes (non-insulin dependent) in patients whose blood sugar level cannot be controlled by treatment with metformin alone. Pioglitazone Teva is given as monotherapy in patients who are unable to take metformin, and whose blood sugar level cannot be controlled by diet or exercise. Likewise, Pioglitazone Teva may also be given in combination with other medicines for treatment of diabetes (such as: metformin, sulphonylurea or insulin) in cases of inadequate control of the blood sugar level. Pioglitazone Teva helps control blood sugar level by improving the response of the body cells to the insulin produced in the body. Therapeutic class: The medicine belongs to the group of thiazolidinediones for treatment of diabetes. 2. BEFORE USING THE MEDICINE Do not use the me Lugege kogu dokumenti